BioAtla
cab effectively reduces clinically relevant toxicity in | BioAtla
Company
Deck Type
Sector
Industry
Deck date
January 2024
Slide
11 of 55
Related slides by other companies
Aeglea BioTherapeutics
Investor Presentation
August 2020
markedly reduces and controls plasma arginine | Aeglea BioTherapeutics
Aeglea BioTherapeutics
Results
May 2020
markedly reduces and controls plasma arginine | Aeglea BioTherapeutics
Bionomics
Results
March 2023
proof of mechanism significantly reduces anxiety and panic symptoms | Bionomics
Aeglea BioTherapeutics
Investor Presentation
June 2020
markedly reduces and controls plasma arginine | Aeglea BioTherapeutics
Other recent decks by BioAtla
See all presentations (8 decks)
Investor Presentation
August 2023
Investor Presentation
May 2023
Investor Presentation
November 2022
Investor Presentation
August 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io